PDA Data Integrity, Data Governance and Data Management Interest Group Virtual Meeting

Hello DIG Members and Industry Professionals!

We are excited to kick-off 2025 with a DIG virtual webinar discussing FDA's recent guidance, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products! PDA is in the midst of commenting on this highly relevant guidance with an expert working team and we at the DIG are looking forward to providing a sneak peek into the team's perspectives! We would also love to hear from all of you and provide our shared community the opportunity to share questions, curiosities', experiences, and insights when it comes to AI and Regulatory Submissions!

Please join IG Leaders Kir Henrici and Ulrich Kollisch on Friday, February 14, at 10:00 AM EST for an interactive session discussing FDA Guidance, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products!

Registration is required for this event. Please register through the link below:

This Interest Group Virtual Meeting will be open to all industry professionals interested in this topic. IG VMs are not recorded and are unique forums for in-depth discussion on specific topics. These discussions are normally reserved as a PDA member benefit.

Please submit questions or topics in advance to your facilitators via [email protected] or by posting on PDA Connect.

Not a member of PDA or the PDA Interest Groups?

Join PDA Become a member of our community

We look forward to engaging with you on this topic!